Gastrointestinal surgery may ameliorate glycemic control in type 2 diabetes mellitus within days to weeks—an effect that cannot be explained solely by the changes in food intake and body weight following gastric bypass. Should clinicians, therefore, implement bariatric procedures to treat type 2 diabetes mellitus in patients who do not meet current obesity-based criteria for surgery?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rubino, F., Kaplan, L. M., Schauer, P. R. & Cummings, D. E. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann. Surg. doi:10.1097/sla.0b013e3181be34e7.
Buchwald H. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292, 1724–1737 (2004).
Sjöström, L. et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 351, 2683–2693 (2004).
Dixon, J. B. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299, 316–323 (2008).
Segato, G. et al. Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding. Surg. Obes. Relat. Dis. doi:10.1016/j.soard.2009.09.014.
Tice, J. A., Karliner, L., Walsh, J., Petersen, A. J. & Feldman, M. D. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am. J. Med. 121, 885–893 (2008).
Chapman, A. E. et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135, 326–351 (2004).
Angrisani, L., Lorenzo, M. & Borrelli, V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg. Obes. Relat. Dis. 3, 127–132 (2007).
Saliba, J., Wattacheril, J. & Abumrad, N. N. Endocrine and metabolic response to gastric bypass. Curr. Opin. Clin. Nutr. Metab. Care 12, 515–521 (2009).
Gumbs, A. A., Modlin, I. M. & Ballantyne, G. H. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes. Surg. 15, 462–473 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Clifton, P. Treatment of type 2 diabetes mellitus with bariatric surgery. Nat Rev Endocrinol 6, 191–193 (2010). https://doi.org/10.1038/nrendo.2010.23
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.23
This article is cited by
-
The effect of rs9939609 FTO gene polymorphism on weight loss after laparoscopic sleeve gastrectomy
Surgical Endoscopy (2016)
-
Brief Report: Approaches to 31P-MRS in Awake, Non-Sedated Children with and without Autism Spectrum Disorder
Journal of Autism and Developmental Disorders (2012)
-
Effects of RS9939609 Gene Variant in FTO Gene on Weight Loss and Cardiovascular Risk Factors After Biliopancreatic Diversion Surgery
Journal of Gastrointestinal Surgery (2012)
-
Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?
Gene Therapy (2011)
-
ESR1, FTO, and UCP2 Genes Interact with Bariatric Surgery Affecting Weight Loss and Glycemic Control in Severely Obese Patients
Obesity Surgery (2011)
